Evidence map›Paper›PMID 40511664›Full record

ArticleBJS open2025

Investigating intraoperative parathyroid hormone criteria for enhanced accuracy and surgical success in treating primary hyperparathyroidism: results from two tertiary referral centres.

Eleonora Lori, Loredana De Pasquale, Alberto M Saibene, Luca Castellani, Daniele Pironi, Piergaspare Palumbo, Domenico Tripodi, Flavio Forte, Corrado De Vito, Gaetano Gallo and 1 more

Abstract readMulticenter Study
In one paragraph

Article in BJS open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Association of preoperative risk factors with therapeutic outcomes in primary hyperparathyroidism: A multivariate analysis of imaging and PTH-Calcium-Phosphate metabolic parameters in 164 cases.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Eleonora LoriDepartment of Surgery, 'Sapienza' University of Rome, Rome, Italy.ORCID 0000-0003-1943-4952
Loredana De PasqualeThyroid and Parathyroid Surgery Service-Otolaryngology Unit, ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, Milan, Italy.
Alberto M SaibeneOtolaryngology Unit, ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, Milan, Italy.
Luca CastellaniOtolaryngology Unit, ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, Milan, Italy.
Daniele PironiDepartment of Surgery, 'Sapienza' University of Rome, Rome, Italy.
Piergaspare PalumboDepartment of Surgery, 'Sapienza' University of Rome, Rome, Italy.
Domenico TripodiDepartment of Surgery, 'Sapienza' University of Rome, Rome, Italy.
Flavio ForteDepartment of Urology, M. G. Vannini Hospital, Rome, Italy.
Corrado De VitoDepartment of Public Health and Infectious Diseases, 'Sapienza' University of Rome, Rome, Italy.
Gaetano GalloDepartment of Surgery, 'Sapienza' University of Rome, Rome, Italy.ORCID 0000-0003-1066-4671
Salvatore SorrentiDepartment of Surgery, 'Sapienza' University of Rome, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrimary hyperparathyroidism is a common endocrine disorder necessitating surgical intervention for definitive treatment. Measurement of intraoperative parathyroid hormone (ioPTH) has revolutionized surgical management, but interpreting the results remains a subject of debate. This retrospective study, evaluated the efficacy of the Miami criterion (a > 50% decrease in ioPTH level 10 minutes after parathyroid removal) in predicting surgical success and whether meeting this criterion reduced persistence rates. It also investigated whether achieving a drop in ioPTH concentration to within the normal range, either alone or in combination with meeting the Miami criterion, led to improved outcomes.

methodsA retrospective analysis was conducted on patients with primary hyperparathyroidism who underwent surgery at two Italian tertiary referral centres. Univariate and multivariate analyses were used to identify predictors of persistence. The diagnostic performances of both ioPTH criteria were assessed, individually and in combination.

resultsData from 380 patients were analysed. Multivariate analysis confirmed the efficacy of both ioPTH criteria, showing a negative association between persistence and both a fall to within the normal range (P = 0.005) and a > 50% decrease in ioPTH level (P = 0.039). The > 50% reduction in ioPTH criterion demonstrated higher sensitivity (95.0%) and lower specificity (45.0%) than the normalization of ioPTH criterion (sensitivity 81.1% and specificity 60.0%). Combining the two criteria resulted in the highest sensitivity (97.5%) and an improved negative predictive value (55.0%) compared with each criterion alone, resulting in the highest accuracy.

conclusionA fall in ioPTH level to within the normal range helps prevent persistence, whereas a drop of > 50% reduces the rate of unnecessary bilateral neck explorations. Combining the two criteria yields the best results in terms of predicting surgical outcome.

Indexed as

Hyperparathyroidism, PrimaryMonitoring, IntraoperativeParathyroidectomyParathyroid HormoneAdultAgedFemaleHumansItalyMaleMiddle AgedMultivariate AnalysisPredictive Value of TestsRetrospective StudiesSensitivity and SpecificityTertiary Care CentersParathyroid Hormone

Identifiers

PMID40511664
PMCPMC12163589

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.